Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Product Unit Size | Cost | Quantity | Stock |
---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
Purity | ≥95% |
---|---|
Formula | C18H25N5O5S |
Formula Wt. | 423.4 |
Synonym | MGP-pNa |
Solubility | Soluble in water. |
Appearance | White to off white powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Lincosamide; ribosomal translocation and protei...
Histamine H1-antagonist
Imidazole; 14-α demethylase inhibitor.
ITC found in cruciferous vegetables, homolog of...
Flavonoid originally found in Silybum (milk thi...
DNA alkylator.
Endogenous peptide hormone; guanyl cyclase C ag...
Thiazolidinedione; PPARα/γ agonist, mitoNEET ...
Steroid; glucocorticoid agonist.
Isoflavone found in legumes such as soy.
Rifampicin derivative; DNA-dependent RNA polyme...
Antioxidant; Nrf2 activator.
Fluoroquinolone; topoisomerase IV and bacterial...
Protein translation inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Casein kinase 1 inhibitor.
PARP inhibitor.
VEGFR inhibitor.
p110β PI3K inhibitor.
VEGFR1/2/3, c-Kit, PDGFR inhibitor.